NUDT10 and posterior cortical atrophy: Kamdar and colleagues performed survival analysis of a PCa patient cohort taken from The Cancer Genome Atlas (TCGA) and showed that reduction in ASB2, NUDT10, and SRPX expression was significantly associated with lower recurrence‐free survival.